Search News
| 16.66 Delayed Data As of Apr 25 |  -0.12 / -0.72%Today’s Change | 3.82 Today|||52-Week Range 26.05 | -0.77% Year-to-Date |
| Previous close | 16.78 |
| Today’s open | 16.73 |
| Day’s range | 16.11 - 16.95 |
| Volume | 361,448 |
| Average volume (3 months) | 805,907 |
| Market cap | $612.6M |
| Earnings growth (last year) | +24.67% |
| Earnings growth (this year) | +58.41% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.12 |
| Today’s change | Today’s % change | |
|---|---|---|
| AVEOAveo Pharmaceuticals... | +0.03 | +1.16% |
| SVASinovac Biotech Ltd | -0.01 | -0.13% |
| CRBPCorbus Pharmaceutica... | -0.05 | -0.79% |
| DEPODepomed Inc | -0.16 | -2.34% |
| Next reporting date | May 9, 2018 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$33.3M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Rachel K. King |
CFO, Secretary & Principal Accounting Officer Brian M. Hahn |
Corporate headquarters Rockville, Maryland |
